Literature DB >> 7973320

Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association.

.   

Abstract

Narcolepsy is a disorder of the central nervous system characterized by excessive sleepiness, cataplexy, and other rapid-eye-movement (REM)-sleep phenomena such as sleep paralysis and hypnagogic hallucinations. Although stimulants are the only effective treatment for the sleepiness of narcolepsy, no clinical guidelines on the use of stimulants in the treatment of narcolepsy have been published that address the following factors: appropriate doses; development of tolerance; potential for side effects, adverse reactions and abuse; and use in children and pregnant or breast-feeding women. These practice parameters from the American Sleep Disorders Association provide the first clinical guidelines on the appropriate use of stimulants in the treatment of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973320

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  9 in total

1.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

Review 2.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

3.  Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Kiran Maski; Lynn Marie Trotti; Suresh Kotagal; R Robert Auger; Todd J Swick; James A Rowley; Sarah D Hashmi; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2021-09-01       Impact factor: 4.324

Review 4.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study.

Authors:  William G Mantyh; R Robert Auger; Timothy I Morgenthaler; Michael H Silber; Wendy R Moore
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

Review 6.  Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Timothy I Morgenthaler; Vishesh K Kapur; Terry Brown; Todd J Swick; Cathy Alessi; R Nisha Aurora; Brian Boehlecke; Andrew L Chesson; Leah Friedman; Rama Maganti; Judith Owens; Jeffrey Pancer; Rochelle Zak
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

Review 7.  Treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Merrill S Wise; Donna L Arand; R Robert Auger; Stephen N Brooks; Nathaniel F Watson
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

8.  An Investigation into the Use of Stimulant Therapy during Pregnancy.

Authors:  Natalie Shields; Rexford Muza; Christopher Kosky; Adrian J Williams
Journal:  Sleep Disord       Date:  2012-09-06

9.  Narcolepsy: current treatment options and future approaches.

Authors:  Michel Billiard
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.